OOIR: Observatory of International Research

Papers

(The H4-Index of BMC Cancer is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Lnc-SELPLG-2:1 enhanced osteosarcoma oncogenesis via hsa-miR-10a-5p and the BTRC cascade	258
Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification	149
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer	126
Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy	119
Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors	116
Exposure–response analyses of cabozantinib in patients with metastatic renal cell cancer	95
The gene expression profile and cell of origin of canine peripheral T-cell lymphoma	86
Changing patterns of nasopharyngeal carcinoma incidence in Hong Kong: a 30-year analysis and future projections	81
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma—randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol	77
Development and psychometric properties of Health-Promoting Lifestyle Scale in Colorectal Cancer Survivors (HPLS-CRCS): a mixed-method study	73
ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer	71
Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database	67
Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer	67
Network Evolution Model-based prediction of tumor mutation burden from radiomic-clinical features in endometrial cancers	67
Rapid and label-free detection of gastrointestinal stromal tumor via a combination of two-photon microscopy and imaging analysis	66
Association of oxaliplatin-containing adjuvant duration with post-treatment fall-related injury and fracture in patients with stage III colon cancer: a population-based retrospective cohort study	65
Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and	61
Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer	59
Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients	58
Increased use of diagnostic CT imaging increases the detection of stage IA lung cancer: pathways and patient characteristics	56
The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma	56
Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up	54
Correlation between overall survival and quality of life in colon cancer patients with chemotherapy	53
NTRK fusion promotes tumor migration and invasion through epithelial–mesenchymal transition and closely interacts with ECM1 and NOVA1	52
Realizing the promise of machine learning in precision oncology: expert perspectives on opportunities and challenges	51

Gross recurrent laryngeal nerve invasion by extranodal extension in thyroid carcinoma	50
Prospective clinical evidence from over 1,000 pan-cancer patients: a complement to fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting	50
Unraveling the causal links and novel molecular classification of Crohn’s disease in breast Cancer: a two-sample mendelian randomization and transcriptome analysis with prognostic modeling	49
Integrated analysis of single-cell and bulk transcriptomics reveals cellular subtypes and molecular features associated with osteosarcoma prognosis	49
The impact of curative cancer treatment on sexual health – clinical results from the EORTC QLQ-SH22 validation study	48
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis	47
Analysis of characteristics of peripheral blood lymphocytes in endometrial carcinoma: a single-center study based on five-year clinical data	47
The mortality rate of people with cancer judged to have a limited life expectancy by physicians performing work disability assessments in the Netherlands: a retrospective cohort study	47
Tertiary lymphoid structures associate with improved survival in early oral tongue cancer	47
Antibiotic use during radical surgery in stage I-III colorectal cancer: correlation with outcomes?	46
Survival impact and risk factors of skeletal muscle loss during first-line EGFR-TKIs therapy in advanced lung adenocarcinoma patients	46
IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communic	45
Impact of perioperative decreased serum albumin level on anastomotic leakage in esophageal squamous cell carcinoma patients treated with neoadjuvant chemotherapy followed by minimally invasive esophag	45
Development and validation of a nomogram for predicting sever cancer-related fatigue in patients with cervical cancer	45
Pseudocapsule thickness is positively associated with prognosis in patients with clear cell renal cell carcinoma	44
Dosimetric effects of bladder volume changes in MR-guided radiotherapy for cervical cancer	43
Prognostic value of tumor-infiltrating CD163+macrophage in patients with metastatic gastric cancer undergoing multidisciplinary treatment	42
Assessing the performance of QLQ-C30 in predicting all-cause mortality in community cancer patients	42
High SNHG expression may predict a poor lung cancer prognosis based on a meta-analysis	42